Document is current
Any future updates will be listed below
-
Authors
Jazowski, Shelley A.
Sico, Isabelle P.
Lindquist, Jennifer H.
Smith, Valerie A.
Bosworth, Hayden B.
Danus, Susanne
Provenzale, Dawn
Kelley, Michael J.
Zullig, Leah L. https://orcid.org/0000-0002-6638-409X
-
Funding
Funding for this research was provided by:
Health Services Research and Development (CDA 13-025, VA HSR&D 08-027)
- License Information
-
More Information
Article History
Received: 6 August 2020
Accepted: 31 March 2021
First Online: 13 April 2021
Declarations
:
: This study and procedures used to obtain implied consent were approved by the Durham VA Health Care System Institutional Review Board (IRB) and performed in accordance with the ethical standards of the Declaration of Helsinki. Participants included in this analysis provided implied consent by returning a completed survey and completed a Health Insurance Portability and Accountability Act (HIPAA) authorization form. Consistent with IRB approval for this research study, permissions to access electronic health records and accompanying data use agreements were obtained from the Veterans Health Administration Patient Care Services and National Data Systems.
: Not Applicable.
: Ms. Jazowski, Ms. Sico, Ms. Lindquist, Ms. Danus, Dr. Smith, and Dr. Provenzale report no conflicts of interest. Dr. Bosworth reports research grants from the PhRMA Foundation, Proteus Digital Health, Otsuka, Novo Nordisk, Sanofi, and Improved Patient Outcomes, as well as consulting from Sanofi, Novartis, Otsuka, Abbott, Preventric Diagnostics, Xcenda and the Medicines Company. Dr. Kelley reports research support from Bavarian Nordic, Novartis, AstraZeneca, and Bristol-Myers Squibb, as well as consulting from IBM Japan and Eisai. Dr. Zullig reports research support from Sanofi, Proteus Digital Health, and the PhRMA Foundation, as well as consulting for Novartis.
